The Market Reports

Synopsis
The global market for Blockchain In Pharmaceutical was estimated to be worth US$ 4667 million in 2024 and is forecast to a readjusted size of US$ 96750 million by 2031 with a CAGR of 55.0% during the forecast period 2025-2031.
Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.
Market Drivers
1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.
2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.
3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.
4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.
5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.
This report aims to provide a comprehensive presentation of the global market for Blockchain In Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blockchain In Pharmaceutical by region & country, by Type, and by Application.
The Blockchain In Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blockchain In Pharmaceutical.
Market Segmentation
By Company
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Segment by Type
Private Blockchain
Hybrid Blockchain
Segment by Application
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blockchain In Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blockchain In Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blockchain In Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index